Cargando…
The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942305/ https://www.ncbi.nlm.nih.gov/pubmed/35298454 http://dx.doi.org/10.15585/mmwr.mm7111a4 |
| _version_ | 1784673280048758784 |
|---|---|
| author | Wallace, Megan Moulia, Danielle Blain, Amy E. Ricketts, Erin K. Minhaj, Faisal S. Link-Gelles, Ruth Curran, Kathryn G. Hadler, Stephen C. Asif, Amimah Godfrey, Monica Hall, Elisha Fiore, Anthony Meyer, Sarah Su, John R. Weintraub, Eric Oster, Matthew E. Shimabukuro, Tom T. Campos-Outcalt, Doug Morgan, Rebecca L. Bell, Beth P. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Oliver, Sara E. |
| author_facet | Wallace, Megan Moulia, Danielle Blain, Amy E. Ricketts, Erin K. Minhaj, Faisal S. Link-Gelles, Ruth Curran, Kathryn G. Hadler, Stephen C. Asif, Amimah Godfrey, Monica Hall, Elisha Fiore, Anthony Meyer, Sarah Su, John R. Weintraub, Eric Oster, Matthew E. Shimabukuro, Tom T. Campos-Outcalt, Doug Morgan, Rebecca L. Bell, Beth P. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Oliver, Sara E. |
| author_sort | Wallace, Megan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8942305 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89423052022-03-31 The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022 Wallace, Megan Moulia, Danielle Blain, Amy E. Ricketts, Erin K. Minhaj, Faisal S. Link-Gelles, Ruth Curran, Kathryn G. Hadler, Stephen C. Asif, Amimah Godfrey, Monica Hall, Elisha Fiore, Anthony Meyer, Sarah Su, John R. Weintraub, Eric Oster, Matthew E. Shimabukuro, Tom T. Campos-Outcalt, Doug Morgan, Rebecca L. Bell, Beth P. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Oliver, Sara E. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-03-18 /pmc/articles/PMC8942305/ /pubmed/35298454 http://dx.doi.org/10.15585/mmwr.mm7111a4 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Wallace, Megan Moulia, Danielle Blain, Amy E. Ricketts, Erin K. Minhaj, Faisal S. Link-Gelles, Ruth Curran, Kathryn G. Hadler, Stephen C. Asif, Amimah Godfrey, Monica Hall, Elisha Fiore, Anthony Meyer, Sarah Su, John R. Weintraub, Eric Oster, Matthew E. Shimabukuro, Tom T. Campos-Outcalt, Doug Morgan, Rebecca L. Bell, Beth P. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Oliver, Sara E. The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022 |
| title | The Advisory Committee on Immunization Practices’
Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18
Years and Considerations for Extended Intervals for Administration of Primary
Series Doses of mRNA COVID-19 Vaccines — United States, February
2022 |
| title_full | The Advisory Committee on Immunization Practices’
Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18
Years and Considerations for Extended Intervals for Administration of Primary
Series Doses of mRNA COVID-19 Vaccines — United States, February
2022 |
| title_fullStr | The Advisory Committee on Immunization Practices’
Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18
Years and Considerations for Extended Intervals for Administration of Primary
Series Doses of mRNA COVID-19 Vaccines — United States, February
2022 |
| title_full_unstemmed | The Advisory Committee on Immunization Practices’
Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18
Years and Considerations for Extended Intervals for Administration of Primary
Series Doses of mRNA COVID-19 Vaccines — United States, February
2022 |
| title_short | The Advisory Committee on Immunization Practices’
Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18
Years and Considerations for Extended Intervals for Administration of Primary
Series Doses of mRNA COVID-19 Vaccines — United States, February
2022 |
| title_sort | advisory committee on immunization practices’
recommendation for use of moderna covid-19 vaccine in adults aged ≥18
years and considerations for extended intervals for administration of primary
series doses of mrna covid-19 vaccines — united states, february
2022 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942305/ https://www.ncbi.nlm.nih.gov/pubmed/35298454 http://dx.doi.org/10.15585/mmwr.mm7111a4 |
| work_keys_str_mv | AT wallacemegan theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT mouliadanielle theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT blainamye theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT rickettserink theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT minhajfaisals theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT linkgellesruth theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT currankathryng theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT hadlerstephenc theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT asifamimah theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT godfreymonica theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT hallelisha theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT fioreanthony theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT meyersarah theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT sujohnr theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT weintrauberic theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT ostermatthewe theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT shimabukurotomt theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT camposoutcaltdoug theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT morganrebeccal theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT bellbethp theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT brooksoliver theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT talbothkeipp theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT leegracem theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT daleymatthewf theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT oliversarae theadvisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT wallacemegan advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT mouliadanielle advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT blainamye advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT rickettserink advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT minhajfaisals advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT linkgellesruth advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT currankathryng advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT hadlerstephenc advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT asifamimah advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT godfreymonica advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT hallelisha advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT fioreanthony advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT meyersarah advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT sujohnr advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT weintrauberic advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT ostermatthewe advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT shimabukurotomt advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT camposoutcaltdoug advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT morganrebeccal advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT bellbethp advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT brooksoliver advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT talbothkeipp advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT leegracem advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT daleymatthewf advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 AT oliversarae advisorycommitteeonimmunizationpracticesrecommendationforuseofmodernacovid19vaccineinadultsaged18yearsandconsiderationsforextendedintervalsforadministrationofprimaryseriesdosesofmrnacovid19vaccinesunitedstatesfebruary2022 |